statistiche ricercatore

Continente	#
NA - Nord America	1.224
AS - Asia	627
EU - Europa	611
SA - Sud America	57
AF - Africa	16
Continente sconosciuto - Info sul continente non disponibili	1
Totale	2.536

Nazione	#
US - Stati Uniti d'America	1.195
SG - Singapore	180
IT - Italia	164
CN - Cina	152
GB - Regno Unito	122
HK - Hong Kong	108
VN - Vietnam	75
DE - Germania	63
SE - Svezia	63
BR - Brasile	39
FI - Finlandia	39
FR - Francia	37
RU - Federazione Russa	32
TR - Turchia	18
CA - Canada	16
IN - India	15
UA - Ucraina	15
ID - Indonesia	14
KR - Corea	14
NL - Olanda	14
BD - Bangladesh	13
BE - Belgio	11
ES - Italia	9
PK - Pakistan	7
AR - Argentina	6
AT - Austria	6
BG - Bulgaria	6
MX - Messico	6
PL - Polonia	5
CZ - Repubblica Ceca	4
EG - Egitto	4
IE - Irlanda	4
IQ - Iraq	4
SK - Slovacchia (Repubblica Slovacca)	4
UZ - Uzbekistan	4
DK - Danimarca	3
EC - Ecuador	3
JP - Giappone	3
KE - Kenya	3
MA - Marocco	3
PH - Filippine	3
VE - Venezuela	3
CH - Svizzera	2
CL - Cile	2
CR - Costa Rica	2
EE - Estonia	2
IL - Israele	2
JM - Giamaica	2
MY - Malesia	2
NO - Norvegia	2
PY - Paraguay	2
SA - Arabia Saudita	2
TN - Tunisia	2
ZA - Sudafrica	2
AE - Emirati Arabi Uniti	1
AM - Armenia	1
AO - Angola	1
AZ - Azerbaigian	1
BY - Bielorussia	1
CO - Colombia	1
CY - Cipro	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
EU - Europa	1
GR - Grecia	1
GY - Guiana	1
IR - Iran	1
JO - Giordania	1
KG - Kirghizistan	1
LB - Libano	1
NI - Nicaragua	1
NP - Nepal	1
OM - Oman	1
PS - Palestinian Territory	1
PT - Portogallo	1
RO - Romania	1
TT - Trinidad e Tobago	1
Totale	2.536

Nome	#
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients	417
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors	391
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia	342
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis	341
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature	304
Investigating the association between physicians self-efficacy regarding communication skills and risk of “burnout”	282
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia	214
Feasibility of autologous peripheral blood stem cell mobilization and harvest in adult patients with FLT3-mutated acute myeloid leukemia receiving chemotherapy combined with midostaurin: a single-center experience	141
Identification and validation of diagnostic cut-offs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients	136
Totale	2.568

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	50	0	0	0	0	0	0	0	0	0	0	38	12
2021/2022	197	9	2	40	8	1	7	11	20	25	16	35	23
2022/2023	207	29	26	14	23	27	12	9	22	19	5	8	13
2023/2024	146	4	3	9	17	21	20	15	32	0	2	8	15
2024/2025	497	16	15	16	23	57	55	45	26	97	16	56	75
2025/2026	831	74	34	65	73	125	48	133	54	103	117	5	0
Totale													2.568